Glycogen synthase kinase-3β inhibition promotes lysosome-dependent degradation of c-FLIPL in hepatocellular carcinoma.

about

Resibufogenin suppresses transforming growth factor-β-activated kinase 1-mediated nuclear factor-κB activity through protein kinase C-dependent inhibition of glycogen synthase kinase 3

P2860

Q58701699-65339FC4-7555-414D-868A-8998A85957D2

P2860

Glycogen synthase kinase-3β inhibition promotes lysosome-dependent degradation of c-FLIPL in hepatocellular carcinoma.

Item

http://www.wikidata.org/entity/Q52694975

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Glycogen synthase kinase-3β in ...... L in hepatocellular carcinoma.

@en

Glycogen synthase kinase-3β in ...... L in hepatocellular carcinoma.

@nl

type

Item

label

Glycogen synthase kinase-3β in ...... L in hepatocellular carcinoma.

@en

Glycogen synthase kinase-3β in ...... L in hepatocellular carcinoma.

@nl

prefLabel

Glycogen synthase kinase-3β in ...... L in hepatocellular carcinoma.

@en

Glycogen synthase kinase-3β in ...... L in hepatocellular carcinoma.

@nl

P1476

Glycogen synthase kinase-3β in ...... L in hepatocellular carcinoma.

@en

P2093

Danqing Song

http://www.w3.org/2001/XMLSchema#string

Hongbin Deng

http://www.w3.org/2001/XMLSchema#string

Lu Liu

http://www.w3.org/2001/XMLSchema#string

Na Zhang

http://www.w3.org/2001/XMLSchema#string

Qingxuan Zeng

http://www.w3.org/2001/XMLSchema#string

Weiqiang Pang

http://www.w3.org/2001/XMLSchema#string

Xiaojia Liu

http://www.w3.org/2001/XMLSchema#string

Yang Liu

http://www.w3.org/2001/XMLSchema#string

Zhesong Deng

http://www.w3.org/2001/XMLSchema#string

P2860

Inhibition of death receptor signals by cellular FLIP

A gene network regulating lysosomal biogenesis and function

Next-generation mTOR inhibitors in clinical oncology: how pathway complexity informs therapeutic strategy

mTOR: from growth signal integration to cancer, diabetes and ageing

Glycogen synthase kinase-3β is a pivotal mediator of cancer invasion and resistance to therapy

Surgical outcomes of hepatocellular carcinoma with biliary tumor thrombus: a systematic review

TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth

Hyperthermia enhances mapatumumab-induced apoptotic death through ubiquitin-mediated degradation of cellular FLIP(long) in human colon cancer cells

Novel phosphorylation and ubiquitination sites regulate reactive oxygen species-dependent degradation of anti-apoptotic c-FLIP protein

The E3 ubiquitin ligase itch couples JNK activation to TNFalpha-induced cell death by inducing c-FLIP(L) turnover

P304

230

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41419-018-0309-3

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-02-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29445085

http://www.w3.org/2001/XMLSchema#string

P932

5833564

http://www.w3.org/2001/XMLSchema#string

Glycogen synthase kinase-3β inhibition promotes lysosome-dependent degradation of c-FLIPL in hepatocellular carcinoma.

about

P2860

P2860

Glycogen synthase kinase-3β inhibition promotes lysosome-dependent degradation of c-FLIPL in hepatocellular carcinoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932